2.47

7.39% 0.17

Tuhura Biosciences Inc (HURA)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$2.30

Offen:

$2.29

24-Stunden-Volumen:

317.09K

Relative Volume:

0.65

Marktkapitalisierung:

$157.30M

Einnahmen:

Nettoeinkommen (Verlust:

$-30.92M

KGV:

-4.0969

EPS:

-0.6029

Netto-Cashflow:

$-27.39M

1W Leistung:

+15.96%

1M Leistung:

+3.78%

6M Leistung:

+85.71%

1J Leistung:

-10.51%

1-Tages-Spanne:

$2.22

$2.49

1-Wochen-Bereich:

$2.115

$2.58

52-Wochen-Spanne:

$0.41

$3.43

Tuhura Biosciences Inc Stock (HURA) Company Profile

Firmenname

Tuhura Biosciences Inc

Sektor

Healthcare (1080)

Branche

Biotechnology (604)

Telefon

813-875-6600

Adresse

10500 UNIVERSITY CENTER DR., TAMPA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

HURA's Discussions on Twitter

Compare HURA vs VRTX, REGN, ARGX, RVMD, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HURA Tuhura Biosciences Inc	2.47	149.02M	0	-30.92M	-27.39M	-0.6029
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-27	Eingeleitet	Citizens	Mkt Outperform
2025-03-03	Eingeleitet	H.C. Wainwright	Buy
2024-12-19	Eingeleitet	Rodman & Renshaw	Buy
2024-11-05	Eingeleitet	Maxim Group	Buy

Tuhura Biosciences Inc Aktie (HURA) Neueste Nachrichten

Aug 14, 2026

TuHURA Biosciences (NASDAQ:HURA) Posts Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Aug 14, 2026

TuHURA Biosciences Highlights Phase III IFx Push, AML Trial Plans at Canaccord - MarketBeat

Aug 14, 2026

TuHURA Biosciences, Inc.Common Stock (HURA) Stock Price, News, Quote & History - FinancialContent

Aug 14, 2026

TuHURA Biosciences Q2 Results: EPS beats estimate, losses narrow 33% YoY - scanx.trade

Aug 14, 2026

TuHURA Secures $50M Credit Facility Extending Cash Runway into 2028 - Minichart

Aug 14, 2026

Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update - TradingView

Aug 14, 2026

Form 8K TuHURA Biosciences Inc For: 14 August By Investing.com - Investing.com Canada

Aug 14, 2026

TuHURA Reports $1.0 Million Cash and Advances TBS-2025 AML Program - quiverquant.com

Aug 14, 2026

TuHURA Bios reports Q2 2026: $1.0M cash, R&D $6.6M, $50M credit facility extends runway - TradingView

Aug 14, 2026

TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update - PR Newswire

Aug 14, 2026

Aug 13, 2026

TuHURA Biosciences Expands Use of Revolving Credit Facility - TipRanks

Aug 13, 2026

Aug 12, 2026

TuHURA at canaccord growth conference: late-stage push gains traction By Investing.com - Investing.com Nigeria

Aug 12, 2026

TuHURA at canaccord growth conference: late-stage push gains traction - Investing.com

Aug 12, 2026

Aug 09, 2026

Enterprise value to EBIT forward of TuHURA Biosciences, Inc. – NASDAQ:HURA - TradingView

Aug 09, 2026

Aug 07, 2026

HURA Q2'26 Earnings: revenue estimate is 0 USD - TradingView

Aug 07, 2026

Aug 06, 2026

TuHURA Biosciences (HURA) Expected to Release Quarterly Earnings on Thursday - MarketBeat

Aug 06, 2026

Jul 28, 2026

TuHURA Biosciences (HURA) Dips 5.9% as Stock Tests Key Support Near $2.00Ichimoku TK Cross - dars.gov.et

Jul 28, 2026

Jul 27, 2026